Author

Marina Rubey

Ludwig-Maximilians-Universität München

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Annabel KitowskiiD· 1 shared Constanze HeiseiD· 1 shared Danica Bajic· 1 shared G. HOEFNERiD· 1 shared Jasmin Hotz· 1 shared Jean‐Luc ColliD· 1 shared Julia Thorn‐SesholdiD· 1 shared Julien VollaireiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Annabel KitowskiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The delivery of nano-formulated drugs to solid tumours is selectively increased by co-application of the vascular disrupting agent CA4P

Annabel Kitowski, Constanze Heise, Stefanie Sperling, Jasmin Hotz, Danica Bajic, Marina Rubey, Kathrin Klar, G. HOEFNER, Julien Vollaire, Véronique Josserand, Jean‐Luc Coll, Oliver Thorn‐Seshold, Petar Marinković, Julia Thorn‐Seshold

This paper shows that co-administering vascular disrupting agents with nanoparticle drugs increases tumoral uptake without increasing systemic exposure.

British Journal of Pharmacology · May 3, 2026Peer-reviewedCancer Biology